NRAS and melanoma: However, we were able to detect low-frequency hotspot mutations, such as NRAS G12/G13, in our healthy skin, nevi, and melanoma sample specimens, suggesting that, due to its increased sensitivity, ddPCR technology can provide new and relevant information for future studies in the field.